Literature DB >> 32254000

Evaluation of factors affecting morbidity and mortality in pneumonectomy patients.

Mustafa Vedat Dogru1, Celal Buğra Sezen1, Cemal Aker1, Oğuz Girgin1, Umut Kilimci1, Semih Erduhan1, Muzaffer Metin1.   

Abstract

BACKGROUND: The aim of this study was to evaluate risk factors associated with morbidity and mortality after pneumonectomy in non-small cell lung cancer patients.
METHODS: The study included 107 patients who underwent pneumonectomy for non-small cell lung cancer between January 2013 and December 2018. Prognostic factors affecting mortality and morbidity were investigated.
RESULTS: The patient group included 10 women (9.3%) and 97 men (90.7%) with a mean age of 59.5 ± 8.5 years. Seventy-three patients (68.2%) underwent standard pneumonectomy and 34 (31.8%) underwent extended pneumonectomy. Nine patients (8.4%) received induction chemotherapy. Complications occurred in 33 patients (30.8%). Complications were classified as surgical, cardiovascular, pulmonary, or infectious. Charlson Comorbidity Index (CCI) > 3 and right-side resection were significant risk factors for the development of complications. The most common complication was atrial fibrillation. Eleven patients developed a bronchopleural fistula. The 30-day postoperative mortality rate was 6.5% (n = 7). Mortality was not associated with any demographic and surgical characteristics other than CCI > 3 (p = .05).
CONCLUSION: The results of this study indicate that our pneumonectomy outcomes are acceptable despite high morbidity and mortality rates. Appropriate patient selection for pneumonectomy is as important as complication management. High-comorbidity patients should undergo these procedures in experienced centers.

Entities:  

Keywords:  Pneumonectomy; morbidity; mortality; non-small cell lung cancer

Mesh:

Year:  2020        PMID: 32254000     DOI: 10.1080/00015458.2020.1753147

Source DB:  PubMed          Journal:  Acta Chir Belg        ISSN: 0001-5458            Impact factor:   1.090


  3 in total

1.  Evaluation of prognostic factors in lung cancers with surgical complete response after induction treatment.

Authors:  Mustafa Vedat Doğru; Celal Buğra Sezen; Cemal Aker; Volkan Erdoğu; Özkan Saydam; Aysun Ölçmen; Levent Cansever; Muzaffer Metin
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2021-04-26       Impact factor: 0.332

2.  Impact of preoperative comorbidities on postoperative complication rate and outcome in surgically resected non-small cell lung cancer patients.

Authors:  Martina Benker; Necati Citak; Thomas Neuer; Isabelle Opitz; Ilhan Inci
Journal:  Gen Thorac Cardiovasc Surg       Date:  2021-09-23

3.  Pneumonectomy for primary lung cancer: contemporary outcomes, risk factors and model validation.

Authors:  Annemarie Brunswicker; Marcus Taylor; Stuart W Grant; Udo Abah; Matthew Smith; Michael Shackcloth; Felice Granato; Rajesh Shah; Kandadai Rammohan
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-06-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.